PPA
BOLT icon

Parametric Portfolio Associates’s Bolt Biotherapeutics BOLT Stock Holding History

Parametric Portfolio Associates’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$50K Buy
+904
New +$60.8K ﹤0.01% 3631

Other funds holding BOLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Parametric Portfolio Associates's BOLT Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Bolt Biotherapeutics (BOLT) in Q1 2022: 904 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #3631 among its holdings.

65 funds tracked by Wall St. Rank hold BOLT as of Q1 2022.

  • Parametric Portfolio Associates held 904 shares of Bolt Biotherapeutics worth $50K as of Q1 2022.
  • Bolt Biotherapeutics was a new Parametric Portfolio Associates position in Q1 2022.
  • Bolt Biotherapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3631 holding.
  • 65 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.